MedPath

The Runny Ear STudy (REST)

Phase 4
Completed
Conditions
Acute otitis media with discharge (AOMd)
Ear, Nose and Throat
Otitis media, unspecified
Registration Number
ISRCTN12873692
Lead Sponsor
The University Of Bristol
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32493407/ protocol (added 06/01/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34816795/ (added 25/11/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
22
Inclusion Criteria

1. Children aged =12 months to <16 years
2. Presenting with recent onset (=7 days) unilateral AOM with recent onset (=7 days) otorrhoea currently visible (or seen by parent/carer =24 hours)
3. Child attending with parent/carer who is legally able to give consent in person or parent able to give verbal consent via telephone call
4. Parent/carer willing and able to administer ear drops
5. Parent/carer willing, able and available to complete the daily SRQ and received regular telephone calls from the study team

Exclusion Criteria

Current exclusion criteria as of 04/12/2018:
1. Symptoms/signs suggestive of bilateral AOM/AOMd
2. Child has symptoms/signs suggestive of serious illness and/or complications e.g. mastoiditis and/or requires immediate hospitalisation
3. Child requires immediate oral antibiotics (e.g. for another infection or AOMd considered severe);
4. As per NICE guidelines13, child at high risk of serious complications:
4.1. Significant immunosuppression
4.2. Heart, lung, renal, liver or neuromuscular disease (defined as requiring ongoing inpatient or outpatient care from specialist teams) co morbidities
4.3. Trisomy 21 (Down’s Syndrome), Cystic Fibrosis or craniofacial malformation such as cleft palate (these children are known to be at higher risk of AOM)
5. Grommet (ventilation tube) in situ in the otorrhoea ear
6. Currently on oral (for a respiratory tract infection) or topical (in the affected ear) antibiotics
7. Allergy to ciprofloxacin
8. Allergy to penicillin/anaphylaxis to another beta lactam agent and allergy to clarithromycin
9. Child has already participated in this trial

Previous exclusion criteria 7 to 9:
7. Known allergy or sensitivity to ciprofloxacin
8. Child has taken part in any research involving medicines within the last 90 days
9. Child has already participated in this trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Time to resolution of all of the following:<br> 1. Pain<br> 2. Fever<br> 3. Being unwell<br> 4. Sleep disturbance<br> 5. Otorrhoea<br> 6. Episodes of distress/crying being rated ‘no’ or ‘very slight’ problem (without need for analgesia)<br> Recorded by parents/carers using a validated Symptom and Recovery Questionnaire (SRQ) with Research Nurse telephone support at baseline to 14 days after randomisation<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath